Le Doussal JM - Search Results

1

Targeting BCL1 lymphoma with anti-idiotype antibodies: biodistribution kinetics of directly labeled antibodies and bispecific antibody-targeted bivalent haptens.

Manetti C, Rouvier E, Gautherot E, Loucif E, Barbet J, Le Doussal JM. Manetti C, et al. Among authors: le doussal jm. Int J Cancer. 1997 Jun 11;71(6):1000-9. doi: 10.1002/(sici)1097-0215(19970611)71:6<1000::aid-ijc16>3.0.co;2-h. Int J Cancer. 1997. PMID: 9185704

2

Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: theoretical, experimental and clinical results.

Le Doussal JM, Barbet J, Delaage M. Le Doussal JM, et al. Int J Cancer Suppl. 1992;7:58-62. Int J Cancer Suppl. 1992. PMID: 1428406 Review.

3

Enhanced in vivo targeting of an asymmetric bivalent hapten to double-antigen-positive mouse B cells with monoclonal antibody conjugate cocktails.

Le Doussal JM, Gautherot E, Martin M, Barbet J, Delaage M. Le Doussal JM, et al. J Immunol. 1991 Jan 1;146(1):169-75. J Immunol. 1991. PMID: 1984443

4

Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.

Le Doussal JM, Gruaz-Guyon A, Martin M, Gautherot E, Delaage M, Barbet J. Le Doussal JM, et al. Cancer Res. 1990 Jun 1;50(11):3445-52. Cancer Res. 1990. PMID: 2334941

5

In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate.

Le Doussal JM, Martin M, Gautherot E, Delaage M, Barbet J. Le Doussal JM, et al. J Nucl Med. 1989 Aug;30(8):1358-66. J Nucl Med. 1989. PMID: 2787847 Free article.

6

Intracellular uptake and catabolism of anti-IgM antibodies and bi-specific antibody-targeted hapten by B-lymphoma cells.

Manetti C, Le Doussal JM, Rouvier E, Gruaz-Guyon A, Barbet J. Manetti C, et al. Among authors: le doussal jm. Int J Cancer. 1995 Oct 9;63(2):250-6. doi: 10.1002/ijc.2910630218. Int J Cancer. 1995. PMID: 7591213

7

Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.

Le Doussal JM, Chetanneau A, Gruaz-Guyon A, Martin M, Gautherot E, Lehur PA, Chatal JF, Delaage M, Barbet J. Le Doussal JM, et al. J Nucl Med. 1993 Oct;34(10):1662-71. J Nucl Med. 1993. PMID: 8410279 Free article.

8

Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten.

Gautherot E, Bouhou J, Le Doussal JM, Manetti C, Martin M, Rouvier E, Barbet J. Gautherot E, et al. Among authors: le doussal jm. Cancer. 1997 Dec 15;80(12 Suppl):2618-23. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2618::aid-cncr37>3.3.co;2-p. Cancer. 1997. PMID: 9406716

9

Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens.

Gautherot E, Le Doussal JM, Bouhou J, Manetti C, Martin M, Rouvier E, Barbet J. Gautherot E, et al. Among authors: le doussal jm. J Nucl Med. 1998 Nov;39(11):1937-43. J Nucl Med. 1998. PMID: 9829586 Free article.

10

Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.

Gautherot E, Rouvier E, Daniel L, Loucif E, Bouhou J, Manetti C, Martin M, Le Doussal JM, Barbet J. Gautherot E, et al. Among authors: le doussal jm. J Nucl Med. 2000 Mar;41(3):480-7. J Nucl Med. 2000. PMID: 10716323 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters